Breadcrumb

RESP  |  Translational Research in Respiratory Diseases Program

RESP Program News

We are proud to celebrate the scientific achievements of our researchers and trainees in publications, grant competitions, honors and awards, and appointments, as well as in the mainstream press.

McGill International TB Centre receives $17.2 M for clinical trials and clinical research on tuberculosis

RI-MUHC researcher Dick Menzies leads international network to fight TB

FALL 2020 CIHR COMPETITION RESULTS

RI-MUHC teams received $6.9 million in project funding and $2 million more for COVID-19 research

Saliva samples for COVID-19 testing: as good as nasopharyngeal swabs, but cheaper

New meta-analysis of 37 studies and over 7,000 paired saliva and nasopharyngeal swab samples

The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients

Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects

What do we know about sleep apnea, pregnancy and gestational diabetes?

RI-MUHC researchers find link that may lead to better health for mother and baby

Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds

A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...

Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds

People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night

Nip it in the bud: New study will attack SARS-Cov2 where it multiplies

RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening

Explore news and events at the RI-MUHC